Jefferies Reiterates a 'Buy' on Health Management (HMA); Adjusting Estimates and PT After Q1 Results

Jefferies reiterates a 'Buy' on Health Management (NYSE: HMA) price target lowered from $11 to $10.

Analyst, Arthur I. Henderson, said, "HMA posted a respectable $0.01 earnings beat in Q1 and reiterated its FY12 EPS outlook of $0.80-$0.90. While weak SS admissions may irk some investors, HMA captured robust outpatient volumes and good pricing-- both of which helped to offset this headwind. At 5.8x FY12 EBITDA, HMA remains attractively valued, in our opinion."

Jefferies lowers FY12 EPS estimate from $1.08 to $0.87 and FY13 from $1.08 to $0.97. FY12 revs cut from $6,455.3mln to $5,652.3mln and FY13 from $6,624.2mln to $5,877.1mln.

For an analyst ratings summary and ratings history on Health Management click here. For more ratings news on Health Management click here.

Shares of Health Management closed at $7.15 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer